Active Ingredient: TERIFLUNOMIDE
Proprietary Name: TERIFLUNOMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 14MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209663
Product Number: 002
Approval Date: Nov 15, 2018
Applicant Holder Full Name: GLENMARK PHARMACEUTICALS SA
Marketing Status:
Prescription
Patent and Exclusivity Information